日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wild-Type RAS Activation in Non-Small Cell Lung Cancer

RAS-GTP抑制剂可克服非小细胞肺癌中由致癌性和野生型RAS激活介导的对KRASG12C抑制剂的获得性耐药性

Solanki, Hitendra S; Shah, Harshit; Imbody, Denis; Desai, Bina; Kato, Ryoji; Miroshnychenko, Daria; Stern, Yaakov E; Majumder, Anurima; Sarcar, Bhaswati; Xieraili, Aobuli; Stewart, Paul A; Fang, Bin; Zhang, Yonghong; Yao, Jiqiang; Darville, Lancia N; Koomen, John M; Rix, Uwe; Evans, James W; Yang, Yu Chi; Ahler, Ethan; Marusyk, Andriy; Singh, Mallika; Aronchik, Ida; Haura, Eric B

Correction: Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

更正:RMC-6236对RAS-GTP抑制在RAS驱动型癌症中的转化和治疗评估

Jiang, Jingjing; Jiang, Lingyan; Maldonato, Benjamin J; Wang, Yingyun; Holderfield, Matthew; Aronchik, Ida; Winters, Ian P; Salman, Zeena; Blaj, Cristina; Menard, Marie; Brodbeck, Jens; Chen, Zhe; Wei, Xing; Rosen, Michael J; Gindin, Yevgeniy; Lee, Bianca J; Evans, James W; Chang, Stephanie; Wang, Zhican; Seamon, Kyle J; Parsons, Dylan; Cregg, James; Marquez, Abby; Tomlinson, Aidan C A; Yano, Jason K; Knox, John E; Quintana, Elsa; Aguirre, Andrew J; Arbour, Kathryn C; Reed, Abby; Gustafson, W Clay; Gill, Adrian L; Koltun, Elena S; Wildes, David; Smith, Jacqueline A M; Wang, Zhengping; Singh, Mallika

In Situ RAS:RAF Binding Correlates with Response to KRASG12C Inhibitors in KRASG12C-Mutant Non-Small Cell Lung Cancer.

原位 RAS:RAF 结合与 KRASG12C 突变型非小细胞肺癌对 KRASG12C 抑制剂的反应相关

Kato Ryoji, Solanki Hitendra S, Ozakinci Hilal, Desai Bina, Gundlapalli Harika, Yang Yu Chi, Aronchik Ida, Singh Mallika, Johnson Joseph, Marusyk Andriy, Boyle Theresa A, Haura Eric B

Genetic mechanisms of resistance to targeted KRAS inhibition.

针对KRAS靶向抑制的耐药遗传机制

Diaz Bianca J, Kops Max, Bernardo Sara, Schmidt Henri, Grankowsky Elizabeth, Vega Adrian, Zhang Chen, Bott Matthew, Skamagki Maria, Tomlinson Aidan, Vita Nicole A, Katti Alyna, Labrecque Mark P, Aronchik Ida, Singh Mallika, Dow Lukas E

Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study

Trotabresib(一种口服强效溴结构域和末端结构域抑制剂)治疗高级别胶质瘤患者的 I 期“机会窗口”研究

Moreno, Victor; Manuel Sepúlveda, Juan; Reardon, David A; Pérez-Núñez, Ángel; González León, Pedro; Hanna, Bishoy; Filvaroff, Ellen; Aronchik, Ida; Chang, Henry; Amoroso, Barbara; Zuraek, Marlene; Sanchez-Perez, Tania; Mendez, Cristina; Stephens, Daniel; Nikolova, Zariana; Vogelbaum, Michael A

Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma

Trotabresib (CC-90010) 联合辅助替莫唑胺或同步替莫唑胺加放疗用于新诊断的胶质母细胞瘤患者

Vieito, Maria; Simonelli, Matteo; de Vos, Filip; Moreno, Victor; Geurts, Marjolein; Lorenzi, Elena; Macchini, Marina; van den Bent, Martin J; Del Conte, Gianluca; de Jonge, Maja; Martín-Soberón, Maria Cruz; Amoroso, Barbara; Sanchez-Perez, Tania; Zuraek, Marlene; Hanna, Bishoy; Aronchik, Ida; Filvaroff, Ellen; Chang, Henry; Mendez, Cristina; Arias Parro, Marina; Wei, Xin; Nikolova, Zariana; Sepulveda, Juan Manuel

The antiproliferative response of indole-3-carbinol in human melanoma cells is triggered by an interaction with NEDD4-1 and disruption of wild-type PTEN degradation

吲哚-3-甲醇在人黑色素瘤细胞中的抗增殖反应是由其与NEDD4-1的相互作用以及对野生型PTEN降解的干扰所触发的。

Aronchik, Ida; Kundu, Aishwarya; Quirit, Jeanne G; Firestone, Gary L

Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity

吲哚-3-甲醇通过激活Rho激酶活性抑制MDA-MB-231乳腺癌细胞的运动,并诱导应力纤维和黏着斑的形成。

Brew, Christine T; Aronchik, Ida; Kosco, Karena; McCammon, Jasmine; Bjeldanes, Leonard F; Firestone, Gary L